Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: A randomised trial

Lancet

Volumn 359, Issue 9314, 2002, Pages 1283-1290

  Erkinjuntti, Timo ^a   Kurz, Alexander ^b   Gauthier, Serge ^c   Bullock, Roger ^d   Lilienfeld, Sean ^e   Damaraju, ChandrasekharRao Venkata ^e  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c MCGILL UNIVERSITY   (Canada)

^d Kingshill Research Centre   (United Kingdom)

^e JANSSEN RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; GALANTAMINE; NICOTINIC RECEPTOR; PLACEBO;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR DISORDER; BRAIN INJURY; CAREGIVER; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; ENZYME INHIBITION; FEMALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIINFARCT DEMENTIA; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME; VOMITING;

EID: 0037070773     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)08267-3     Document Type: Article

References (29)

1. Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts
2. Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts
3. Frequency of stroke in Europe: A collaborative study of population-based cohorts
4. Cerebrovascular dementia. Pathophysiology, diagnosis and treatment
5. Prevalence and outcomes of vascular cognitive impairment
6. Rethinking vascular dementia
7. Subtypes of vascular dementia
8. Brain infarction and the clinical expression of Alzheimer disease: The Nun Study
9. Vascular factors and Alzheimer disease
10. Overlap between pathology of Alzheimer disease and vascular dementia
11. Pharmacological evaluation of novel Alzheimer's disease therapeutics: Acetylcholinesterase inhibitors related to galanthamine
12. Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer's disease
13. A 5-month, randomized, placebo-controlled trial of galantamine in Alzheimer's disease
14. Galantamine in AD: A 6-month, randomized, placebo-controlled trial with a 6-month extension
15. Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: A multicentre randomised controlled trial
16. Vascular dementia: Diagnostic criteria for research studies-report of the NINDS-AIREN International Workshop
17. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS/ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease
18. "Mini-Mental State": A practical method for grading the cognitive state of patients for the clinician
19. A new rating scale for Alzheimer's disease
20. Development of a functional measure for persons with Alzheimer's disease: The disability assessment for dementia
21. Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change
22. The Neuropsychiatric Inventory: Assessing psychopathology in dementia patients
23. On the combination of independent two-sample tests of Wilcoxon
24. Statistical aspects of the analysis of data from retrospective studies of disease
25. An efficacy and safety analysis of Exelon® in Alzheimer's disease patients with concurrent vascular risk factors
26. Outcome measures for probable vascular dementia and Alzheimer's disease with cerebrovascular disease
27. Use of donepezil for vascular dementia: Preliminary clinical experience
28. Diagnosis of vascular dementia and Alzheimer's disease
29. Sensitivity and specificity of newly proposed clinical criteria for possible vascular dementia